Global Cell and Gene Therapy Drug Delivery Devices Market Growth (Status and Outlook) 2022-2028
- LP 4893459
- 111 Pages
- March 2022
- Medical Devices
The United States Cell and Gene Therapy Drug Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cell and Gene Therapy Drug Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Cell and Gene Therapy Drug Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cell and Gene Therapy Drug Delivery Devices players cover Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, and Bluebird bio, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Drug Delivery Devices market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size 2017-2028
2.1.2 Cell and Gene Therapy Drug Delivery Devices Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cell and Gene Therapy Drug Delivery Devices Segment by Type
2.2.1 Sterile Insulin Syringe
2.2.2 Pre-Filled Syringe
2.2.3 Infusion Bags
2.3 Cell and Gene Therapy Drug Delivery Devices Market Size by Type
2.3.1 Cell and Gene Therapy Drug Delivery Devices Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2022)
2.4 Cell and Gene Therapy Drug Delivery Devices Segment by Application
2.4.1 Luxturna
2.4.2 Kymriah
2.4.3 Provenge
2.4.4 Zolgensma
2.4.5 Yescarta
2.4.6 Strimvelis
2.5 Cell and Gene Therapy Drug Delivery Devices Market Size by Application
2.5.1 Cell and Gene Therapy Drug Delivery Devices Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2022)
3 Cell and Gene Therapy Drug Delivery Devices Market Size by Player
3.1 Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2020-2022)
3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2020-2022)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Drug Delivery Devices by Regions
4.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Regions (2017-2022)
4.2 Americas Cell and Gene Therapy Drug Delivery Devices Market Size Growth (2017-2022)
4.3 APAC Cell and Gene Therapy Drug Delivery Devices Market Size Growth (2017-2022)
4.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size Growth (2017-2022)
4.5 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Growth (2017-2022)
5 Americas
5.1 Americas Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
5.2 Americas Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
5.3 Americas Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022)
6.2 APAC Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
6.3 APAC Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell and Gene Therapy Drug Delivery Devices by Country (2017-2022)
7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices by Region (2017-2022)
8.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
8.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.1 Global Cell and Gene Therapy Drug Delivery Devices Forecast by Regions (2023-2028)
10.1.1 Global Cell and Gene Therapy Drug Delivery Devices Forecast by Regions (2023-2028)
10.1.2 Americas Cell and Gene Therapy Drug Delivery Devices Forecast
10.1.3 APAC Cell and Gene Therapy Drug Delivery Devices Forecast
10.1.4 Europe Cell and Gene Therapy Drug Delivery Devices Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Forecast
10.2 Americas Cell and Gene Therapy Drug Delivery Devices Forecast by Country (2023-2028)
10.2.1 United States Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.2.2 Canada Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.2.3 Mexico Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.2.4 Brazil Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.3 APAC Cell and Gene Therapy Drug Delivery Devices Forecast by Region (2023-2028)
10.3.1 China Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.3.2 Japan Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.3.3 Korea Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.3.5 India Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.3.6 Australia Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.4 Europe Cell and Gene Therapy Drug Delivery Devices Forecast by Country (2023-2028)
10.4.1 Germany Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.4.2 France Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.4.3 UK Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.4.4 Italy Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.4.5 Russia Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Forecast by Region (2023-2028)
10.5.1 Egypt Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.5.2 South Africa Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.5.3 Israel Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.5.4 Turkey Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Drug Delivery Devices Market Forecast
10.6 Global Cell and Gene Therapy Drug Delivery Devices Forecast by Type (2023-2028)
10.7 Global Cell and Gene Therapy Drug Delivery Devices Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amgen, Inc.
11.1.1 Amgen, Inc. Company Information
11.1.2 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amgen, Inc. Main Business Overview
11.1.5 Amgen, Inc. Latest Developments
11.2 Bausch and Lomb Incorporated
11.2.1 Bausch and Lomb Incorporated Company Information
11.2.2 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Offered
11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bausch and Lomb Incorporated Main Business Overview
11.2.5 Bausch and Lomb Incorporated Latest Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Information
11.3.2 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Offered
11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Becton, Dickinson and Company Main Business Overview
11.3.5 Becton, Dickinson and Company Latest Developments
11.4 Bluebird bio, Inc.
11.4.1 Bluebird bio, Inc. Company Information
11.4.2 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bluebird bio, Inc. Main Business Overview
11.4.5 Bluebird bio, Inc. Latest Developments
11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Information
11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Offered
11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Main Business Overview
11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Latest Developments
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Dendreon Pharmaceuticals LLC. Company Information
11.6.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.6.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Information
11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Offered
11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Main Business Overview
11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Latest Developments
11.8 Human Stem Cell Institute
11.8.1 Human Stem Cell Institute Company Information
11.8.2 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Offered
11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Human Stem Cell Institute Main Business Overview
11.8.5 Human Stem Cell Institute Latest Developments
11.9 Kite Pharma, Inc.
11.9.1 Kite Pharma, Inc. Company Information
11.9.2 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Kite Pharma, Inc. Main Business Overview
11.9.5 Kite Pharma, Inc. Latest Developments
11.10 Kolon Tissue Gene, inc.
11.10.1 Kolon Tissue Gene, inc. Company Information
11.10.2 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Kolon Tissue Gene, inc. Main Business Overview
11.10.5 Kolon Tissue Gene, inc. Latest Developments
11.11 Novartis AG
11.11.1 Novartis AG Company Information
11.11.2 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Offered
11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Novartis AG Main Business Overview
11.11.5 Novartis AG Latest Developments
11.12 Orchard Therapeutics plc.
11.12.1 Orchard Therapeutics plc. Company Information
11.12.2 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Orchard Therapeutics plc. Main Business Overview
11.12.5 Orchard Therapeutics plc. Latest Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Information
11.13.2 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Pfizer, Inc. Main Business Overview
11.13.5 Pfizer, Inc. Latest Developments
11.14 Renova Therapeutics
11.14.1 Renova Therapeutics Company Information
11.14.2 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Offered
11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Renova Therapeutics Main Business Overview
11.14.5 Renova Therapeutics Latest Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Information
11.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Spark Therapeutics, Inc. Main Business Overview
11.15.5 Spark Therapeutics, Inc. Latest Developments
11.16 uniQure N.V.
11.16.1 uniQure N.V. Company Information
11.16.2 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Offered
11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 uniQure N.V. Main Business Overview
11.16.5 uniQure N.V. Latest Developments
11.17 Vericel Corporation
11.17.1 Vericel Corporation Company Information
11.17.2 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Offered
11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Vericel Corporation Main Business Overview
11.17.5 Vericel Corporation Latest Developments
12 Research Findings and Conclusion
Table 1. Cell and Gene Therapy Drug Delivery Devices Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Sterile Insulin Syringe
Table 3. Major Players of Pre-Filled Syringe
Table 4. Major Players of Infusion Bags
Table 5. Cell and Gene Therapy Drug Delivery Devices Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2022)
Table 8. Cell and Gene Therapy Drug Delivery Devices Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2022)
Table 11. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Player (2020-2022)
Table 13. Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Regions (2017-2022)
Table 19. Americas Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Country (2017-2022)
Table 21. Americas Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2022)
Table 23. Americas Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2022)
Table 25. APAC Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Region (2017-2022)
Table 27. APAC Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2022)
Table 29. APAC Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2022)
Table 31. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Country (2017-2022)
Table 33. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2022)
Table 35. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Drug Delivery Devices
Table 44. Key Market Challenges & Risks of Cell and Gene Therapy Drug Delivery Devices
Table 45. Key Industry Trends of Cell and Gene Therapy Drug Delivery Devices
Table 46. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share Forecast by Application (2023-2028)
Table 52. Amgen, Inc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 53. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 54. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Amgen, Inc. Main Business
Table 56. Amgen, Inc. Latest Developments
Table 57. Bausch and Lomb Incorporated Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 58. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 59. Bausch and Lomb Incorporated Main Business
Table 60. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bausch and Lomb Incorporated Latest Developments
Table 62. Becton, Dickinson and Company Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 63. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 64. Becton, Dickinson and Company Main Business
Table 65. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Becton, Dickinson and Company Latest Developments
Table 67. Bluebird bio, Inc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 68. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 69. Bluebird bio, Inc. Main Business
Table 70. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Bluebird bio, Inc. Latest Developments
Table 72. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 73. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 74. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Main Business
Table 75. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Latest Developments
Table 77. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 78. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 79. Dendreon Pharmaceuticals LLC. Main Business
Table 80. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Dendreon Pharmaceuticals LLC. Latest Developments
Table 82. Helixmith Co., Ltd (ViroMed Co., Ltd) Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 83. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 84. Helixmith Co., Ltd (ViroMed Co., Ltd) Main Business
Table 85. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Helixmith Co., Ltd (ViroMed Co., Ltd) Latest Developments
Table 87. Human Stem Cell Institute Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 88. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 89. Human Stem Cell Institute Main Business
Table 90. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Human Stem Cell Institute Latest Developments
Table 92. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 93. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 94. Kite Pharma, Inc. Main Business
Table 95. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Kite Pharma, Inc. Latest Developments
Table 97. Kolon Tissue Gene, inc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 98. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 99. Kolon Tissue Gene, inc. Main Business
Table 100. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Kolon Tissue Gene, inc. Latest Developments
Table 102. Novartis AG Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 103. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 104. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments
Table 107. Orchard Therapeutics plc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 108. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 109. Orchard Therapeutics plc. Main Business
Table 110. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Orchard Therapeutics plc. Latest Developments
Table 112. Pfizer, Inc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 113. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 114. Pfizer, Inc. Main Business
Table 115. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Pfizer, Inc. Latest Developments
Table 117. Renova Therapeutics Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 118. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 119. Renova Therapeutics Main Business
Table 120. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Renova Therapeutics Latest Developments
Table 122. Spark Therapeutics, Inc. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 123. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 124. Spark Therapeutics, Inc. Main Business
Table 125. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Spark Therapeutics, Inc. Latest Developments
Table 127. uniQure N.V. Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 128. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 129. uniQure N.V. Main Business
Table 130. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. uniQure N.V. Latest Developments
Table 132. Vericel Corporation Details, Company Type, Cell and Gene Therapy Drug Delivery Devices Area Served and Its Competitors
Table 133. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Offered
Table 134. Vericel Corporation Main Business
Table 135. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Vericel Corporation Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Drug Delivery Devices Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type in 2021
Figure 7. Cell and Gene Therapy Drug Delivery Devices in Luxturna
Figure 8. Global Cell and Gene Therapy Drug Delivery Devices Market: Luxturna (2017-2022) & ($ Millions)
Figure 9. Cell and Gene Therapy Drug Delivery Devices in Kymriah
Figure 10. Global Cell and Gene Therapy Drug Delivery Devices Market: Kymriah (2017-2022) & ($ Millions)
Figure 11. Cell and Gene Therapy Drug Delivery Devices in Provenge
Figure 12. Global Cell and Gene Therapy Drug Delivery Devices Market: Provenge (2017-2022) & ($ Millions)
Figure 13. Cell and Gene Therapy Drug Delivery Devices in Zolgensma
Figure 14. Global Cell and Gene Therapy Drug Delivery Devices Market: Zolgensma (2017-2022) & ($ Millions)
Figure 15. Cell and Gene Therapy Drug Delivery Devices in Yescarta
Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market: Yescarta (2017-2022) & ($ Millions)
Figure 17. Cell and Gene Therapy Drug Delivery Devices in Strimvelis
Figure 18. Global Cell and Gene Therapy Drug Delivery Devices Market: Strimvelis (2017-2022) & ($ Millions)
Figure 19. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2021
Figure 20. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Player in 2021
Figure 21. Global Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Cell and Gene Therapy Drug Delivery Devices Market Size 2017-2022 ($ Millions)
Figure 23. APAC Cell and Gene Therapy Drug Delivery Devices Market Size 2017-2022 ($ Millions)
Figure 24. Europe Cell and Gene Therapy Drug Delivery Devices Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size 2017-2022 ($ Millions)
Figure 26. Americas Cell and Gene Therapy Drug Delivery Devices Value Market Share by Country in 2021
Figure 27. Americas Cell and Gene Therapy Drug Delivery Devices Consumption Market Share by Type in 2021
Figure 28. Americas Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2021
Figure 29. United States Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Region in 2021
Figure 34. APAC Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2021
Figure 35. China Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Country in 2021
Figure 42. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type in 2021
Figure 43. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2021
Figure 44. Germany Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2021
Figure 52. Egypt Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Cell and Gene Therapy Drug Delivery Devices Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 58. APAC Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 59. Europe Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 61. United States Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 62. Canada Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 65. China Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 66. Japan Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 67. Korea Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 69. India Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 70. Australia Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 71. Germany Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 72. France Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 73. UK Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 74. Italy Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 75. Russia Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 76. Spain Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 79. Israel Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Cell and Gene Therapy Drug Delivery Devices Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
